Literature DB >> 16733081

Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cells.

Ling Song1, Richard S Jope.   

Abstract

Modulation of the expression of regulator of G-protein signaling (RGS) proteins is a major mechanism used to modulate their actions. Besides control by second messengers, the expression of RGS proteins, particularly RGS2, can be regulated by cell stress. Because RGS2 and RGS4 expression can be regulated by the cell cycle, we examined if cell cycle signals are involved in their regulation following stress. Treatment of SH-SY5Y cells with camptothecin increased RGS2 mRNA and decreased RGS4 mRNA levels. This effect on RGS2 mRNA was blocked by the cyclin-dependent kinase-2 (cdk2) inhibitors roscovitine and purvalanol. Cell cycle arrest was further implicated in regulating RGS mRNA levels because geldanamycin, which causes cell cycle arrest by inhibiting the actions of heat shock protein 90, caused changes in the mRNA levels of RGS2 and RGS4 similar to, and additive with, the effects of camptothecin. Overall, these results indicate that cell cycle arrest regulates the expression of RGS2 and RGS4, and that the expression of these two RGS family members is oppositely regulated by stress that causes cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733081      PMCID: PMC1618799          DOI: 10.1016/j.neulet.2006.03.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Muscarinic receptor stimulation increases regulators of G-protein signaling 2 mRNA levels through a protein kinase C-dependent mechanism.

Authors:  L Song; P De Sarno; R S Jope
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 2.  ATP-site directed inhibitors of cyclin-dependent kinases.

Authors:  N Gray; L Détivaud; C Doerig; L Meijer
Journal:  Curr Med Chem       Date:  1999-09       Impact factor: 4.530

Review 3.  Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins.

Authors:  F S Willard; M F Crouch
Journal:  Immunol Cell Biol       Date:  2000-08       Impact factor: 5.126

Review 4.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement.

Authors:  William B Pratt; Mario D Galigniana; Jennifer M Harrell; Donald B DeFranco
Journal:  Cell Signal       Date:  2004-08       Impact factor: 4.315

5.  DNA damage induces cdk2 protein levels and histone H2B phosphorylation in SH-SY5Y neuroblastoma cells.

Authors:  Xiaoyi Yu; John Caltagarone; Mark A Smith; Robert Bowser
Journal:  J Alzheimers Dis       Date:  2005-09       Impact factor: 4.472

6.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

Authors:  L Meijer; A Borgne; O Mulner; J P Chong; J J Blow; N Inagaki; M Inagaki; J G Delcros; J P Moulinoux
Journal:  Eur J Biochem       Date:  1997-01-15

Review 8.  Pathways governing G1/S transition and their response to DNA damage.

Authors:  J Bartek; J Lukas
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

Review 9.  Hsp90 activation and cell cycle regulation.

Authors:  Francis Burrows; Hong Zhang; Adeela Kamal
Journal:  Cell Cycle       Date:  2004-12-30       Impact factor: 4.534

10.  Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

Authors:  L Whitesell; E G Mimnaugh; B De Costa; C E Myers; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  9 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

Review 2.  Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.

Authors:  Joseph B O'Brien; Joshua C Wilkinson; David L Roman
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

3.  RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.

Authors:  Jaebeom Cho; Hye-Young Min; Ho Jin Lee; Seung Yeob Hyun; Jeong Yeon Sim; Myungkyung Noh; Su Jung Hwang; Shin-Hyung Park; Hye-Jin Boo; Hyo-Jong Lee; Sungyoul Hong; Rang-Woon Park; Young Kee Shin; Mien-Chie Hung; Ho-Young Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 4.  Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling.

Authors:  Benita Sjögren; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-07-27       Impact factor: 4.436

5.  RGS2 is a feedback inhibitor of melatonin production in the pineal gland.

Authors:  Masahiro Matsuo; Steven L Coon; David C Klein
Journal:  FEBS Lett       Date:  2013-03-21       Impact factor: 4.124

6.  Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle.

Authors:  Fang Li; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Gene       Date:  2009-11-26       Impact factor: 3.688

7.  Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.

Authors:  Kimberly C Boelte; Laura E Gordy; Sebastian Joyce; Mary Ann Thompson; Li Yang; P Charles Lin
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

8.  Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer.

Authors:  Jana Ihlow; Nanna Monjé; Inga Hoffmann; Philip Bischoff; Bruno Valentin Sinn; Wolfgang Daniel Schmitt; Catarina Alisa Kunze; Sylvia Darb-Esfahani; Hagen Kulbe; Elena Ioana Braicu; Jalid Sehouli; Carsten Denkert; David Horst; Eliane Tabea Taube
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

9.  Translational control by RGS2.

Authors:  Chau H Nguyen; Hong Ming; Peishen Zhao; Lynne Hugendubler; Robert Gros; Scot R Kimball; Peter Chidiac
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.